Microbiota Injury is Conditioning Regimen-Dependent in Allogeneic Hematopoietic Cell Transplantation Recipients

被引：0
|
作者：
Shouval, Roni [1 ]
Gomes, Antonio [1 ]
Chi Nguyen [1 ]
Markey, Kate Ann [1 ]
Dai, Anqi [1 ]
Brambilla, Corrado Zuanelli [1 ]
Taur, Ying [1 ]
Scordo, Mike [1 ]
Giralt, Sergio A. [1 ]
Perales, Miguel-Angel [1 ]
van den Brink, Marcel R. M. [1 ]
Peled, Jonathan U. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
BONE MARROW TRANSPLANTATION | 2021年 / 56卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O045
引用
收藏
页码：54 / 56
页数：3
相关论文
共 50 条
  • [31] Treosulfan and fludarabine:: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation
    Casper, J
    Knauf, W
    Kiefer, T
    Wolff, D
    Steiner, B
    Hammer, U
    Wegener, R
    Kleine, HD
    Wilhelm, S
    Knopp, A
    Hartung, G
    Dölken, G
    Freund, M
    BLOOD, 2004, 103 (02) : 725 - 731
  • [32] Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
    K Fujimaki
    J Taguchi
    H Fujita
    M Hattori
    E Yamazaki
    N Takahashi
    S Fujisawa
    H Kanamori
    A Maruta
    Y Ishigatsubo
    Bone Marrow Transplantation, 2004, 33 : 789 - 792
  • [33] Allogeneic hematopoietic cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen.
    Gürman, G
    Üstün, C
    Arslan, Ö
    Beksaç, M
    Konuk, N
    Arat, M
    Çelebi, H
    Özcan, M
    Ilhan, O
    Demirer, T
    Akan, H
    Uysal, A
    Koç, H
    BONE MARROW TRANSPLANTATION, 1999, 23 : S22 - S22
  • [34] Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
    Fujimaki, K
    Taguchi, J
    Fujita, H
    Hattori, M
    Yamazaki, E
    Takahashi, N
    Fujisawa, S
    Kanamori, H
    Maruta, A
    Ishigatsubo, Y
    BONE MARROW TRANSPLANTATION, 2004, 33 (08) : 789 - 792
  • [35] Allogeneic hematopoietic stem cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen.
    Gürman, G
    Üstün, C
    Arslan, O
    Beksaç, M
    Konuk, N
    Arat, M
    Celebi, H
    Özcan, M
    Ilhan, O
    Demirer, T
    Akan, H
    Uysal, A
    Koc, H
    BLOOD, 1998, 92 (10) : 350B - 351B
  • [36] The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen
    Giraud, Geraldine
    Bogdanovic, Gordana
    Priftakis, Peter
    Remberger, Mats
    Svahn, Britt-Marie
    Barkholt, Lisbeth
    Ringden, Olle
    Winiarski, Jacek
    Ljungman, Per
    Dalianis, Tina
    HAEMATOLOGICA, 2006, 91 (03) : 401 - 404
  • [37] Impact Of Conditioning Regimen, Donor Source, and DIPSS Score On Outcome Of Allogeneic Hematopoietic Stem Cell Transplantation For Myelofibrosis
    Kroeger, Nicolaus
    Ditschkowski, Markus
    Scott, Bart L.
    Zabelina, Tatjana
    Alchalby, Haefaa
    Beelen, Dietrich
    Deeg, H. Joachim
    BLOOD, 2013, 122 (21)
  • [38] The comparison of myeloablative versus reduced intensity conditioning regimen in ABO mismatched allogeneic hematopoietic cell transplantation.
    Topcuoglu, P
    Arat, M
    Bolukbasi, T
    Soydan, E
    Ozer, Y
    Ozcan, M
    Gorman, G
    Demirer, T
    Akan, H
    Beksac, M
    Arslan, O
    Ilhan, O
    BLOOD, 2004, 104 (11) : 370B - 370B
  • [39] Once daily intravenous busulfan as part of a busulfan/cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation
    Mates, M
    Michalska, H
    Hasegawa, W
    Kiss, T
    Daly, A
    Loach, D
    Messner, H
    Lipton, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 36 - 36
  • [40] Antibody based conditioning for allogeneic hematopoietic stem cell transplantation
    Saha, Asim
    Blazar, Bruce R.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345